Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
69 studies found for:    "hereditary angioedema"
Show Display Options
Rank Status Study
21 Recruiting Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Intervention: Drug: C1 esterase inhibitor [human] liquid
22 Terminated Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema
Conditions: Hereditary Angioedema;   HAE
Intervention: Drug: avoralstat
23 Completed
Has Results
C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)
Condition: Hereditary Angioedema
Intervention: Drug: C1 Esterase Inhibitor
24 Completed
Has Results
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Interventions: Biological: C1 Esterase Inhibitor;   Biological: Placebo
25 Completed
Has Results
C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf);   Drug: Placebo (saline)
26 Completed
Has Results
C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf);   Drug: Placebo (saline)
27 Enrolling by invitation Long-term Safety and Efficacy Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
Condition: Hereditary Angioedema
Intervention: Drug: DX-2930
28 Active, not recruiting A Call Center During HAE Attacks (SOS HAE)
Condition: Hereditary Angioedema
Intervention: Other: phone to the call center
29 Active, not recruiting Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE
Condition: Hereditary Angioedema
Interventions: Drug: DX-2930 - 300mg/2wk;   Drug: DX-2930 - 300mg/4wk;   Drug: DX-2930 150mg/4wk;   Drug: Placebo
30 Completed A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
Condition: Hereditary Angioedema
Interventions: Biological: Recombinant human C1 inhibitor;   Other: Placebo
31 Completed
Has Results
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
Conditions: Hereditary Angioedema;   Angioneurotic Edema
Interventions: Drug: Recombinant Human C1 Inhibitor;   Drug: placebo
32 Recruiting C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
33 Completed Berinert P Study of Subcutaneous Versus Intravenous Administration
Condition: Hereditary Angioedema
Intervention: Drug: C1-Esterase Inhibitor
34 Completed
Has Results
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
35 Completed
Has Results
Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE with rHuPH20
36 Completed
Has Results
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE
Condition: Hereditary Angioedema
Intervention: Biological: C1 inhibitor (human) [C1 INH]
37 Completed
Has Results
Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
38 Completed Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE
Condition: Hereditary Angioedema
Interventions: Drug: BCX4161;   Drug: Placebo
39 Completed
Has Results
EASSI - Evaluation of the Safety of Self-Administration With Icatibant
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
40 Completed
Has Results
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.